Angiogenin-Stimulated rRNA Transcription Is Essential for Initiation and Survival of AKT-Induced Prostate Intraepithelial Neoplasia
Open Access
- 17 March 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 7 (3) , 415-424
Abstract
Angiogenin (ANG), originally identified as an angiogenic ribonuclease, has recently been shown to play a direct role in prostate cancer cell proliferation by mediating rRNA transcription. ANG is up-regulated in human prostate cancer and is the most significantly up-regulated gene in AKT-driven prostate intraepithelial neoplasia (PIN) in mice. Enhanced cell proliferation in the PIN lesions requires increased ribosome biogenesis, a multistep process involving an orchestrated production of ribosomal proteins and rRNA. AKT is known to enhance ribosomal protein production through the mammalian target of rapamycin pathway. However, it was unknown how rRNA is proportionally increased. Here, we report that ANG is essential for AKT-driven PIN formation and survival. We showed that up-regulation of ANG in the AKT-overexpressing mouse prostates is an early and lasting event. It occurs before PIN initiation and lasts beyond PIN is fully developed. Knocking down ANG expression by intraprostate injection of lentivirus-mediated ANG-specific small interfering RNA prevents AKT-induced PIN formation without affecting AKT expression and its signaling through the mammalian target of rapamycin pathway. Neomycin, an aminoglycoside that blocks nuclear translocation of ANG, and N65828, a small-molecule enzymatic inhibitor of the ribonucleolytic activity of ANG, both prevent AKT-induced PIN formation and reverse established PIN. They also decrease nucleolar organizer region, restore cell size, and normalize luminal architectures of the prostate despite continuous activation of AKT. All three types of the ANG inhibitor suppress rRNA transcription of the prostate luminal epithelial cells and inhibit AKT-induced PIN, indicating an essential role of ANG in AKT-mediated cell proliferation and survival. (Mol Cancer Res 2009;7(3):415–24)Keywords
This publication has 52 references indexed in Scilit:
- Potent antitumor effects of a novel actinomycin D analog Leu5AMDCancer Letters, 2008
- Potential therapeutic implications of intracrine angiogenesisMedical Hypotheses, 2007
- A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferationProceedings of the National Academy of Sciences, 2006
- Mapping ribosomal RNA transcription activity in the mouse eyeDevelopmental Dynamics, 2006
- Neamine Inhibits Xenografic Human Tumor Growth and Angiogenesis in Athymic MiceClinical Cancer Research, 2005
- Pten Dose Dictates Cancer Progression in the ProstatePLOS Biology, 2003
- Identification and Characterization of an Angiogenin-Binding DNA Sequence That Stimulates Luciferase Reporter Gene ExpressionBiochemistry, 2002
- Regulation of cell size in growth, development and human disease: PI3K, PKB and S6KBioEssays, 2002
- Modulation of the activity of angiogenin by mutagenesis at Asp-116Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1993
- Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogeninBiochemistry, 1992